- Home
- KLTR vs STTK Comparison
KLTR vs STTK Comparison
Compare KLTR & STTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KLTR
- STTK
- Stock Information
- Founded
- KLTR 2006
- STTK 2016
- Country
- KLTR United States
- STTK United States
- Employees
- KLTR N/A
- STTK N/A
- Industry
- KLTR EDP Services
- STTK Biotechnology: Pharmaceutical Preparations
- Sector
- KLTR Technology
- STTK Health Care
- Exchange
- KLTR Nasdaq
- STTK Nasdaq
- Market Cap
- KLTR 302.6M
- STTK 37.6M
- IPO Year
- KLTR 2021
- STTK 2020
- Fundamental
- Price
- KLTR $1.99
- STTK $0.83
- Analyst Decision
- KLTR Buy
- STTK Hold
- Analyst Count
- KLTR 3
- STTK 4
- Target Price
- KLTR $2.83
- STTK $3.00
- AVG Volume (30 Days)
- KLTR 369.0K
- STTK 401.8K
- Earning Date
- KLTR 08-07-2025
- STTK 07-31-2025
- Dividend Yield
- KLTR N/A
- STTK N/A
- EPS Growth
- KLTR N/A
- STTK N/A
- EPS
- KLTR N/A
- STTK N/A
- Revenue
- KLTR $180,920,000.00
- STTK $4,606,000.00
- Revenue This Year
- KLTR $3.46
- STTK N/A
- Revenue Next Year
- KLTR $3.67
- STTK N/A
- P/E Ratio
- KLTR N/A
- STTK N/A
- Revenue Growth
- KLTR 2.40
- STTK 69.65
- 52 Week Low
- KLTR $1.06
- STTK $0.69
- 52 Week High
- KLTR $2.82
- STTK $4.99
- Technical
- Relative Strength Index (RSI)
- KLTR 44.51
- STTK 39.19
- Support Level
- KLTR $1.92
- STTK $0.77
- Resistance Level
- KLTR $2.06
- STTK $0.91
- Average True Range (ATR)
- KLTR 0.11
- STTK 0.08
- MACD
- KLTR -0.00
- STTK -0.02
- Stochastic Oscillator
- KLTR 49.06
- STTK 16.23
About KLTR Kaltura Inc.
Kaltura Inc provides live and on-demand video SaaS solutions to thousands of organizations around the world, engaging hundreds of millions of viewers at home, at work, and at school. It also offers specialized industry solutions, including Learning Management System Video, Lecture Capture, and Virtual Classroom for educational institutions, as well as a TV Solution for media and telecom companies. It operates in two reporting segments which are Enterprise, Education, and Technology, and Media and Telecom. The majority of the revenue is derived from Enterprise, Education & Technology. The majority of the revenue is earned from the United States.
About STTK Shattuck Labs Inc.
Shattuck Labs Inc is a biotechnology company specializing in the development of potential treatments for inflammatory and immune-mediated diseases. It is developing a potentially first-in-class antibody for the treatment of inflammatory bowel disease (IBD) and other inflammatory and immune-mediated diseases. The company's expertise in protein engineering and the development of novel tumor necrosis factor (TNF) receptor therapeutics comes together in its main program, SL-325, which has the potential to be a first-in-class death receptor 3 (DR3) antagonist antibody. In addition, the company is developing SL-425, a half-life extended version of SL-325, and multiple other preclinical DR3-based bispecific antibodies, for the treatment of patients with IBD.